| Literature DB >> 26760242 |
Howard Ramirez-Malule1, Stefan Junne2, Carlos López3, Julian Zapata3, Alex Sáez4, Peter Neubauer2, Rigoberto Rios-Estepa5.
Abstract
Clavulanic acid (CA) is an important secondary metabolite commercially produced by cultivation of Streptomyces clavuligerus (Sc). It is a potent inhibitor of bacterial β-lactamases. In this work, a specific and improved high performance liquid chromatography (HPLC) method, using a C-18 reversed phase column, diode array detector and gradient elution for CA quantification in fermentation broths of Sc, was developed and successfully validated. Samples were imidazole-derivatized for the purpose of creating a stable chromophore (clavulanate-imidazole). The calibration curve was linear over a typical range of CA concentration between 0.2 and 400mg/L. The detection and quantification limits were 0.01 and 0.02mg/L, respectively. The precision of the method was evaluated for CA spiked into production media and a recovery of 103.8%, on average, was obtained. The clavulanate-imidazole complex was not stable when the samples were not cooled during the analysis. The recovery rate was 39.3% on average. This assay was successfully tested for CA quantification in samples from Sc fermentation, using both, a chemically defined and a complex medium.Entities:
Keywords: Clavulanate–imidazole; Clavulanic acid; Fermentation processes; High performance liquid chromatography method; Streptomyces clavuligerus
Mesh:
Substances:
Year: 2015 PMID: 26760242 DOI: 10.1016/j.jpba.2015.12.035
Source DB: PubMed Journal: J Pharm Biomed Anal ISSN: 0731-7085 Impact factor: 3.935